Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Up 27.5% in February

Beyond Air, Inc. (NASDAQ:XAIRGet Free Report) was the recipient of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 1,530,000 shares, an increase of 27.5% from the February 13th total of 1,200,000 shares. Based on an average trading volume of 1,550,000 shares, the days-to-cover ratio is currently 1.0 days. Currently, 2.8% of the shares of the company are short sold.

Beyond Air Trading Down 5.9 %

Shares of XAIR stock opened at $0.28 on Wednesday. Beyond Air has a 12 month low of $0.24 and a 12 month high of $1.78. The stock has a market capitalization of $19.52 million, a P/E ratio of -0.27 and a beta of 0.16. The firm’s 50 day moving average is $0.35 and its 200 day moving average is $0.40.

Beyond Air (NASDAQ:XAIRGet Free Report) last posted its earnings results on Monday, February 10th. The company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.09. Beyond Air had a negative net margin of 1,730.00% and a negative return on equity of 226.01%. During the same quarter last year, the firm posted ($0.50) EPS. On average, equities analysts predict that Beyond Air will post -0.79 EPS for the current year.

Insider Buying and Selling at Beyond Air

In other Beyond Air news, Director Robert Carey bought 1,000,000 shares of the business’s stock in a transaction on Friday, March 14th. The stock was purchased at an average price of $0.25 per share, for a total transaction of $250,000.00. Following the completion of the transaction, the director now directly owns 4,076,864 shares of the company’s stock, valued at $1,019,216. This trade represents a 32.50 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 20.10% of the company’s stock.

Institutional Trading of Beyond Air

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Squarepoint Ops LLC bought a new position in Beyond Air during the fourth quarter valued at approximately $48,000. Wealthedge Investment Advisors LLC bought a new stake in shares of Beyond Air in the 4th quarter valued at about $80,000. Baldwin Wealth Partners LLC MA boosted its holdings in Beyond Air by 721.3% during the 4th quarter. Baldwin Wealth Partners LLC MA now owns 308,000 shares of the company’s stock valued at $110,000 after acquiring an additional 270,500 shares during the period. Geode Capital Management LLC grew its position in Beyond Air by 81.0% during the 4th quarter. Geode Capital Management LLC now owns 562,713 shares of the company’s stock worth $202,000 after acquiring an additional 251,823 shares during the last quarter. Finally, Soros Fund Management LLC bought a new stake in Beyond Air in the 3rd quarter worth $573,000. Hedge funds and other institutional investors own 31.50% of the company’s stock.

Beyond Air Company Profile

(Get Free Report)

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.

See Also

Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.